Correlations between the MV-PGC and SS patient plasma inflammatory molecule concentrations
| Soluble molecule . | r (Spearman) . | P . |
|---|---|---|
| Elastase | 0.6 | .005 |
| sCD40L | 0.56 | .01 |
| PDGF-AB/BB | 0.48 | .03 |
| TGF-α | 0.46 | .04 |
| TSP-1 | 0.28 | .23 |
| FGF-2 | 0.21 | .37 |
| IL-10 | 0.17 | .48 |
| Resistin | 0.15 | .53 |
| TNF-α | 0.1 | .66 |
| IL-8 | −0.04 | .84 |
| G-CSF | 0.03 | .88 |
| IL-6 | 0.03 | .91 |
| Soluble molecule . | r (Spearman) . | P . |
|---|---|---|
| Elastase | 0.6 | .005 |
| sCD40L | 0.56 | .01 |
| PDGF-AB/BB | 0.48 | .03 |
| TGF-α | 0.46 | .04 |
| TSP-1 | 0.28 | .23 |
| FGF-2 | 0.21 | .37 |
| IL-10 | 0.17 | .48 |
| Resistin | 0.15 | .53 |
| TNF-α | 0.1 | .66 |
| IL-8 | −0.04 | .84 |
| G-CSF | 0.03 | .88 |
| IL-6 | 0.03 | .91 |
P ≤ .05 was considered a significant nonparametric correlation (Spearman’s correlation). Only significant correlations were included in the table.